Suppr超能文献

相似文献

1
Improving nucleoside analogs via lipid conjugation: Is fatter any better?
Crit Rev Oncol Hematol. 2016 Apr;100:46-56. doi: 10.1016/j.critrevonc.2016.01.015. Epub 2016 Jan 21.
2
Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer.
Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1168-80. doi: 10.1080/15257770.2011.607143.
3
The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.
Cancer Metastasis Rev. 2007 Mar;26(1):85-110. doi: 10.1007/s10555-007-9044-4.
4
Evaluation of tetraether lipid-based liposomal carriers for encapsulation and retention of nucleoside-based drugs.
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4319-4322. doi: 10.1016/j.bmcl.2017.08.032. Epub 2017 Aug 16.
5
Lipid-conjugated nucleoside monophosphate and monophosphonate prodrugs: A versatile drug delivery paradigm.
Eur J Med Chem. 2024 Sep 5;275:116614. doi: 10.1016/j.ejmech.2024.116614. Epub 2024 Jun 22.
7
Is it still worth renewing nucleoside anticancer drugs nowadays?
Eur J Med Chem. 2024 Jan 15;264:115987. doi: 10.1016/j.ejmech.2023.115987. Epub 2023 Nov 24.
8
Recent developments to improve the efficacy of cytotoxic nucleoside analogues.
Recent Pat Anticancer Drug Discov. 2006 Jun;1(2):163-70. doi: 10.2174/157489206777442205.
9
Nucleoside transporters: biological insights and therapeutic applications.
Future Med Chem. 2012 Jul;4(11):1461-78. doi: 10.4155/fmc.12.79.

引用本文的文献

1
Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies.
Front Cell Dev Biol. 2023 Apr 18;11:1173432. doi: 10.3389/fcell.2023.1173432. eCollection 2023.
2
Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs.
Biochemistry. 2019 Jul 23;58(29):3204-3211. doi: 10.1021/acs.biochem.9b00530. Epub 2019 Jul 10.
3
Molecular Modeling-Guided Design of Phospholipid-Based Prodrugs.
Int J Mol Sci. 2019 May 5;20(9):2210. doi: 10.3390/ijms20092210.
4
Prospects and Challenges of Phospholipid-Based Prodrugs.
Pharmaceutics. 2018 Nov 1;10(4):210. doi: 10.3390/pharmaceutics10040210.
5
The ProTide Prodrug Technology: From the Concept to the Clinic.
J Med Chem. 2018 Mar 22;61(6):2211-2226. doi: 10.1021/acs.jmedchem.7b00734. Epub 2017 Aug 24.

本文引用的文献

1
Effects of cholesterol concentration on the interaction of cytarabine with lipid membranes: a molecular dynamics simulation study.
J Biomol Struct Dyn. 2015;33(6):1254-68. doi: 10.1080/07391102.2014.941936. Epub 2014 Jul 28.
7
Liposomes for brain delivery.
Expert Opin Drug Deliv. 2013 Jul;10(7):1003-22. doi: 10.1517/17425247.2013.766714. Epub 2013 Feb 4.
8
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.
Invest New Drugs. 2013 Aug;31(4):959-66. doi: 10.1007/s10637-013-9925-z. Epub 2013 Jan 24.
9
In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation.
Cancer Chemother Pharmacol. 2013 Feb;71(2):379-88. doi: 10.1007/s00280-012-2017-5. Epub 2012 Nov 10.
10
Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer.
Ther Adv Med Oncol. 2012 Nov;4(6):341-6. doi: 10.1177/1758834012453755.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验